Abstract
Aim: To test the efficacy of an aid to cessation/relapse prevention intervention for women postpartum. Method: Two-armed randomized controlled trial. Follow-ups at 6, 12, 18, and 24 months, screenings on maternity wards. Intervention group received face-to-face counseling 40 days postpartum plus telephone counseling calls 4 and 12 weeks later. Control group received usual care plus self-help material for each parent. Results: With regard to smoking cessation, 4 week point prevalence abstinent rates were higher in the treatment group at 6, 12, and 18 months (7% vs. 1%, 7% vs. 2%, and 9% vs. 1%, respectively). Sustained abstinence was higher in the treatment group at 6 months follow-up (3% vs. 0%). No difference was observed with regard to relapse prevention. Discussion: Regarding aid to cessation we observed small effects, regarding relapse prevention no effect. In order to capitalize on the opportunity childbirth poses with regard to smoking, theories on relapse prevention in smoking cessation that guide in designing interventions are needed.
| Original language | English |
|---|---|
| Journal | Addictive Behaviors |
| Volume | 34 |
| Issue number | 1 |
| Pages (from-to) | 1-8 |
| Number of pages | 8 |
| ISSN | 0306-4603 |
| DOIs | |
| Publication status | Published - 01.2009 |
Funding
This study was part of the Research Collaboration in Early Substance Use Interventions (EARLINT), and was funded by the German Federal Ministry of Education and Research (grant no.: 01EB0120), by the Social Ministry of the Federal State of Mecklenburg–West Pomerania (grant no.: IX311a 406.68.43.05) and the Krupp von Bohlen and Halbach Foundation.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of 'Smoking cessation and relapse prevention for postpartum women: Results from a randomized controlled trial at 6, 12, 18 and 24 months'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver